2-101004304-C-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000993.5(RPL31):c.233+21C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0101 in 1,611,914 control chromosomes in the GnomAD database, including 1,358 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.053 ( 714 hom., cov: 32)
Exomes 𝑓: 0.0056 ( 644 hom. )
Consequence
RPL31
NM_000993.5 intron
NM_000993.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.37
Genes affected
RPL31 (HGNC:10334): (ribosomal protein L31) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L31E family of ribosomal proteins. It is located in the cytoplasm. Higher levels of expression of this gene in familial adenomatous polyps compared to matched normal tissues have been observed. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 2-101004304-C-G is Benign according to our data. Variant chr2-101004304-C-G is described in ClinVar as [Benign]. Clinvar id is 1233833.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPL31 | NM_000993.5 | c.233+21C>G | intron_variant | Intron 3 of 4 | ENST00000264258.8 | NP_000984.1 | ||
RPL31 | NM_001098577.3 | c.233+21C>G | intron_variant | Intron 3 of 4 | NP_001092047.1 | |||
RPL31 | NM_001099693.2 | c.233+21C>G | intron_variant | Intron 3 of 3 | NP_001093163.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0526 AC: 7982AN: 151692Hom.: 711 Cov.: 32
GnomAD3 genomes
AF:
AC:
7982
AN:
151692
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0135 AC: 3345AN: 247240Hom.: 276 AF XY: 0.0100 AC XY: 1345AN XY: 134530
GnomAD3 exomes
AF:
AC:
3345
AN:
247240
Hom.:
AF XY:
AC XY:
1345
AN XY:
134530
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00563 AC: 8222AN: 1460104Hom.: 644 Cov.: 31 AF XY: 0.00488 AC XY: 3543AN XY: 726270
GnomAD4 exome
AF:
AC:
8222
AN:
1460104
Hom.:
Cov.:
31
AF XY:
AC XY:
3543
AN XY:
726270
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0528 AC: 8010AN: 151810Hom.: 714 Cov.: 32 AF XY: 0.0517 AC XY: 3833AN XY: 74190
GnomAD4 genome
AF:
AC:
8010
AN:
151810
Hom.:
Cov.:
32
AF XY:
AC XY:
3833
AN XY:
74190
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
40
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
May 18, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at